Selvita

Selvita company information, Employees & Contact Information

Explore related pages

Related company profiles:

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.

Company Details

Employees
782
Founded
-
Address
Podole 79, Kraków,lesser Poland Voivodeship 30-394,poland
Phone
+48 12 297 47 00
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Kraków, Lesser Poland Voivodeship
Looking for a particular Selvita employee's phone or email?

Selvita Questions

News

Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services - Yahoo Finance

Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services Yahoo Finance

Recent uptick might appease Selvita S.A. (WSE:SLV) institutional owners after losing 40% over the past year - simplywall.st

Recent uptick might appease Selvita S.A. (WSE:SLV) institutional owners after losing 40% over the past year simplywall.st

Now available on the German Market: Selvita - Cigar Journal

Now available on the German Market: Selvita Cigar Journal

Selvita S.A. (WSE:SLV) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - simplywall.st

Selvita S.A. (WSE:SLV) Stock Catapults 25% Though Its Price And Business Still Lag The Industry simplywall.st

Translational pathology in drug discovery - Frontiers

Translational pathology in drug discovery Frontiers

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24 - European Medical Journal

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24 European Medical Journal

Selvita's growth continues with completion of new Krakow HQ - Fierce Biotech

Selvita's growth continues with completion of new Krakow HQ Fierce Biotech

Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory - researchgate.net

Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory researchgate.net

Poland: Selvita expands capabilities with completion of PozLab acquisition - Investors in Healthcare

Poland: Selvita expands capabilities with completion of PozLab acquisition Investors in Healthcare

Poland’s Selvita to split into two listed companies - The Pharma Letter

Poland’s Selvita to split into two listed companies The Pharma Letter

Selvita to cash in €90m in Menarini deal - European Biotechnology Magazine

Selvita to cash in €90m in Menarini deal European Biotechnology Magazine

Is Selvita (WSE:SLV) Using Too Much Debt? - simplywall.st

Is Selvita (WSE:SLV) Using Too Much Debt? simplywall.st

Selvita appoints new Chief Medical Officer - European Biotechnology Magazine

Selvita appoints new Chief Medical Officer European Biotechnology Magazine

Top Selvita Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant